RIM
CAI

Rakuten Investment Management’s Caris Life Sciences CAI Stock Holding History

Rakuten Investment Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,518
Closed -$2.79M – 648
2025
Q3 		$2.79M Buy
+14,518
New +$463K 0.01% 347

Other funds holding CAI

JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rakuten Investment Management's CAI Position: Q4 2025 in Review

Rakuten Investment Management sold out of Caris Life Sciences (CAI) in Q4 2025, closing a stake of 14,518 shares — an estimated $2.79M sold.

Rakuten Investment Management first reported a position in CAI in Q3 2025 and held it in 1 quarter. The position peaked at $2.79M in Q3 2025. 186 funds tracked by Wall St. Rank hold CAI as of Q4 2025.

  • Rakuten Investment Management reported no remaining Caris Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Rakuten Investment Management sold 14,518 Caris Life Sciences shares in Q4 2025, an estimated $2.79M.
  • Rakuten Investment Management first reported a position in Caris Life Sciences in Q3 2025 and held it in 1 quarter.
  • Rakuten Investment Management's Caris Life Sciences position peaked at $2.79M in Q3 2025.
  • 186 funds tracked by Wall St. Rank held Caris Life Sciences as of Q4 2025.

Based on Rakuten Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.